<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Yonsei Med J</journal-id>
      <journal-id journal-id-type="publisher-id">YMJ</journal-id>
      <journal-title-group>
        <journal-title>Yonsei Medical Journal</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0513-5796</issn>
      <issn pub-type="epub">1976-2437</issn>
      <publisher>
        <publisher-name>Yonsei University College of Medicine</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">18581601</article-id>
      <article-id pub-id-type="pmc">2615353</article-id>
      <article-id pub-id-type="doi">10.3349/ymj.2008.49.3.496</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Case of Ischemic Colitis Associated with the Herbal Food Supplement Ma Huang</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Song</surname>
            <given-names>Hyun Joo</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Shim</surname>
            <given-names>Ki-Nam</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ryu</surname>
            <given-names>Kum Hei</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kim</surname>
            <given-names>Tae Hun</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jung</surname>
            <given-names>Sung-Ae</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Yoo</surname>
            <given-names>Kwon</given-names>
          </name>
          <xref ref-type="aff" rid="A1"/>
        </contrib>
      </contrib-group>
      <aff id="A1">Department of Internal Medicine, Ewha Medical Research Institute, Ewha Womans University School of Medicine, Seoul, Korea.</aff>
      <author-notes>
        <corresp>
Reprint address: requests to Dr. Ki-Nam Shim, Department of Internal Medicine, Ewha Womans University Mokdong Hospital, 911-1 Mok-dong, Yangcheon-gu, Seoul 158-710, Korea. Tel: 82-2-2650-2632, Fax: 82-2-2655-2076, <email>shimkn@ewha.ac.kr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <day>30</day>
        <month>6</month>
        <year>2008</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>20</day>
        <month>6</month>
        <year>2008</year>
      </pub-date>
      <volume>49</volume>
      <issue>3</issue>
      <fpage>496</fpage>
      <lpage>499</lpage>
      <history>
        <date date-type="received">
          <day>24</day>
          <month>10</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>01</day>
          <month>12</month>
          <year>2006</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>Copyright &#xA9; 2008 The Yonsei University College of Medicine</copyright-statement>
        <copyright-year>2008</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">
          <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0">http://creativecommons.org/licenses/by-nc/3.0</ext-link>) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Ischemic colitis is a condition that usually occurs in the elderly, as a form of vascular disease. However, ischemic colitis also occurs, though rarely, in healthy young adults. Moreover, food supplements containing Ephedra sinica or ma huang have been linked to adverse central nervous and cardiovascular events. A 40-year-old man was admitted to our emergency department after 2 episodes of abdominal pain and bloody diarrhea that lasted 24 hours. His medical history was unremarkable for risk factors of bowel ischemia, except for well-controlled hypertension. However, a weight-loss supplement, Ephedra sinica, had been prescribed for daily use during the previous month. Both abdominal/pelvic computed tomography and colonoscopy revealed findings compatible with ischemic colitis. His conditions spontaneously improved without any serious complications, and he was advised to discontinue the use of herbal medications containing ephedrine. In this paper, we describe a case of ischemic colitis that was potentially linked to the use of ma huang with a review of the relevant literature.</p>
      </abstract>
      <kwd-group>
        <kwd>Ischemic colitis</kwd>
        <kwd>ephedra sinica</kwd>
        <kwd>ma huang</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Ischemic colitis results from the same conditions that cause hypoperfusion or embolic/thrombotic occlusion of the vascular supply of the colon.<xref ref-type="bibr" rid="B1">1</xref> Many factors may be involved in the hypoperfusive state that results in ischemic colitis. Nonocclusive ischemia is now a well-recognized condition, though its pathophysiology is still not completely understood.<xref ref-type="bibr" rid="B2">2</xref> Vasoconstrictive medications may be implicated in some cases of nonocclusive ischemia. These medications include digitalis, diuretics, estrogen, cocaine, pseudoephedrine, methamphetamine, vasopressin, alosetron, and non-steroidal anti-inflammatory drugs.<xref ref-type="bibr" rid="B1">1</xref>,<xref ref-type="bibr" rid="B2">2</xref></p>
      <p>Ephedra sinica or ma huang is an evergreen shrub native to Central Asia, and its primary component is ephedrine.<xref ref-type="bibr" rid="B3">3</xref> Food supplements containing ephedra alkaloids have been linked to adverse cardiovascular and central nervous events.<xref ref-type="bibr" rid="B4">4</xref> Additionally, a case of ischemic colitis associated with the use of an herbal product was reported in a young woman.<xref ref-type="bibr" rid="B5">5</xref> In this paper, we examine the strong association between the use of ma huang and the development of ischemic colitis.</p>
    </sec>
    <sec sec-type="cases">
      <title>CASE REPORT</title>
      <p>A 40-year-old man was admitted to our emergency department with abdominal pain and bloody diarrhea. The patient had watery diarrhea for 3 days, but 3 hours prior to presentation, it became bloody. He had neither a history of symptoms suggestive of an inflammatory bowel disease nor a recent history of antibiotic use. In addition, he had neither a history of recent travel nor a diet change. His medical history was unremarkable for risk factors of bowel ischemia, except for hypertension that was well controlled with angiotensin receptor blockers. He smoked 1 pack of cigarette per day for 10 years, and there was no family history of cerebrovascular or cardivascular disease. Notably, he had been taking an herbal food supplement, Ephedra sinica or ma huang (total 1,000 mg; 3 times/day) throughout the previous month for weight loss.</p>
      <p>His blood pressure was 110/70 mmHg, pulse rate 73/min, respiratory rate 20/min, and body temperature 36.5&#x2103;. His body mass index was 25.7 kg/m<sup>2</sup>. The patient appeared acutely ill but otherwise was a healthy, well-nourished man. His abdomen was soft and obese with mild tenderness in the periumbilical area, and his bowel sounds were normoactive. Laboratory data on admission showed hemoglobin 15.6 g/dL, hematocrit 44.4%, white blood cell count 7,500/mm<sup>3</sup>, and platelet 214,000/mm<sup>3</sup>. His serum sodium level was 138 mmol/L, potassium 4.1 mmol/L, chloride 103 mmol/L, fasting glucose 98 mg/dL, serum albumin 3.9 g/dL, total cholesterol 145 mg/dL, triglyceride 75 mg/dL, LDL cholesterol 81 mg/dL, blood urea nitrogen 10 mg/dL, and creatinine 1.2 mg/dL. The patient's coagulation profiles were normal. The stool white blood cell test was negative, while the stool occult blood test was positive. Stool specimens were negative for enteric pathogens.</p>
      <p>Abdominal and pelvic CT scans showed a patent superior mesenteric artery and circumferential wall thickening of the ascending, transverse, and descending colon sparing the rectosigmoid junction (<xref ref-type="fig" rid="F1">Fig. 1</xref>). Colonoscopy performed on admission showed findings compatible with segmental colitis extending from the ascending to the descending colon. The involved areas were edematous and hyperemic, with areas of frank hemorrhage (<xref ref-type="fig" rid="F2">Fig. 2A</xref>). Three days after intravenous hydration and nutritional support, the bloody diarrhea resolved. At an 8-day follow-up, colonoscopy showed markedly improved mucosa without any complications (<xref ref-type="fig" rid="F2">Fig. 2B</xref>). The colonoscopic biopsy specimen of the affected area showed focal mucosal erosion and chronic inflammatory cell infiltration consistent with ischemic colitis (<xref ref-type="fig" rid="F3">Fig. 3</xref>).</p>
      <p>The patient completely recovered without complications and with only conservative management. On discharge, he was advised to discontinue the use of herbal medications and to avoid any ephedrine- or pseudoephedrine-containing cold remedies.</p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Herbal weight loss supplements are popular and may even be effective. Ma huang is a source of ephedrine, a long-acting sympathomimetic that acts primarily through the release of stored catecholamine via &#x3B1;- and &#x3B2;-adrenoreceptors.<xref ref-type="bibr" rid="B5">5</xref> Ephedra and ephedrine are sometimes used to achieve weight loss or to enhance athletic performance, but the efficacy and safety of these compounds are uncertain.<xref ref-type="bibr" rid="B6">6</xref> Moreover, during the past decade, a considerable number of reports regarding the adverse effects of ephedra have led to an increased awareness of the danger of these sympathomimetics. For example, herbal ephedra and ephedrine-containing food supplements have been reported to increase the risks of adverse psychiatric, autonomic, and gastrointestinal events.<xref ref-type="bibr" rid="B6">6</xref> Furthermore, ephedrine and related alkaloids have been associated with adverse cardiovascular events, including acute myocardial infarction, severe hypertension, myocarditis, and lethal cardiac arrhythmia.<xref ref-type="bibr" rid="B7">7</xref>-<xref ref-type="bibr" rid="B9">9</xref> Ephedrine can also predispose patients to both hemorrhagic and ischemic stroke.<xref ref-type="bibr" rid="B10">10</xref></p>
      <p>Ephedrine and ephedra are found to promote short-term weight loss in clinical trials, but no data are available regarding long-term weight loss.<xref ref-type="bibr" rid="B6">6</xref> A recent study found that products containing ephedra accounted for 64% of all adverse reactions to herbal supplements reported to the US poison control centers in 2001, even though they accounted for only 1% of the herbal supplement market.<xref ref-type="bibr" rid="B11">11</xref> Although a number of clinical trials have reported adverse events associated with Ephedria sinica,<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref> information regarding the supplement is still incomplete. Ma huang is considered to be potentially safe by the Food and Drug Administration (FDA) when used orally for a maximum of 7 days and in maximum doses of 24 mg/day of ephedrine equivalent.<xref ref-type="bibr" rid="B15">15</xref> However, in light of recently reported adverse events, the FDA has proposed limits on the dose and duration of these supplements.<xref ref-type="bibr" rid="B4">4</xref> In this case, the patient was taking ma huang in a dose about 6 times higher than is recommended by the FDA. It is not surprising, therefore, that ischemic colitis developed in this patient. Infectious etiologies were also ruled out with stool analysis.</p>
      <p>Injury to the colon, especially ischemic colitis, in patients using ma huang is presumably related to reduced splanchnic blood flow due to vasoconstrictions such as those seen in myocardial infarction<xref ref-type="bibr" rid="B8">8</xref> and ischemic stroke.<xref ref-type="bibr" rid="B10">10</xref> Potentially at-risk areas include sites in the splenic flexure, descending colon, and occasionally the rectosigmoid junction. The areas between the superior and inferior mesenteric arteries and between the lower sigmoid and superior rectal arteries are known as 'watershed' areas.<xref ref-type="bibr" rid="B5">5</xref></p>
      <p>Recently, a few cases of ischemic colitis have been reported to be linked with decongestant use.<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B17">17</xref> In each of these cases, the vasoconstrictive properties of pseudoephedrine were believed to be the possible cause of ischemic colitis. Moreover, ischemic colitis after a dietary supplementation with phenteramine, an amphetamine-derived sympathomimetic, has been reported.<xref ref-type="bibr" rid="B18">18</xref> Although our patient did not take decongestant medications, his herbal diet supplements contained ephedrine products, which were similar to pseudoephedrine and caffeine products.<xref ref-type="bibr" rid="B12">12</xref>-<xref ref-type="bibr" rid="B14">14</xref></p>
      <p>It is important to keep in mind that many healthy people take a variety of herbal medications, believing that these medications are completely harmless. However, herbal products have many active ingredients with pharmacologic properties that may have undesirable effects. This paper suggests that use of ma huang, a known sympathomimetic and vasoconstrictor, carries a risk for ischemic colitis in healthy people.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <ref id="B1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sreenarasimhaiah</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and management of intestinal ischaemic disorders</article-title>
          <source>BMJ</source>
          <year>2003</year>
          <volume>326</volume>
          <fpage>1372</fpage>
          <lpage>1376</lpage>
          <pub-id pub-id-type="pmid">12816826</pub-id>
        </element-citation>
      </ref>
      <ref id="B2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>MacDonald</surname>
              <given-names>PH</given-names>
            </name>
          </person-group>
          <article-title>Ischaemic colitis</article-title>
          <source>Best Pract Res Clin Gastroenterol</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>51</fpage>
          <lpage>61</lpage>
          <pub-id pub-id-type="pmid">11977928</pub-id>
        </element-citation>
      </ref>
      <ref id="B3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pittler</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Schmidt</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Ernst</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Adverse events of herbal food supplements for body weight reduction: systematic review</article-title>
          <source>Obes Rev</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>93</fpage>
          <lpage>111</lpage>
          <pub-id pub-id-type="pmid">15836459</pub-id>
        </element-citation>
      </ref>
      <ref id="B4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haller</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Benowitz</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids</article-title>
          <source>N Engl J Med</source>
          <year>2000</year>
          <volume>343</volume>
          <fpage>1833</fpage>
          <lpage>1838</lpage>
          <pub-id pub-id-type="pmid">11117974</pub-id>
        </element-citation>
      </ref>
      <ref id="B5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ryan</surname>
              <given-names>CK</given-names>
            </name>
            <name>
              <surname>Reamy</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Rochester</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Ischemic colitis associated with herbal product use in a young woman</article-title>
          <source>J Am Board Fam Pract</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>309</fpage>
          <lpage>312</lpage>
          <pub-id pub-id-type="pmid">12150465</pub-id>
        </element-citation>
      </ref>
      <ref id="B6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Shekelle</surname>
              <given-names>PG</given-names>
            </name>
            <name>
              <surname>Hardy</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Morton</surname>
              <given-names>SC</given-names>
            </name>
            <name>
              <surname>Maglione</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Mojica</surname>
              <given-names>WA</given-names>
            </name>
            <name>
              <surname>Suttorp</surname>
              <given-names>MJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Efficacy and safety of ephedra and ephedrine for weight loss and athletic performance: a meta-analysis</article-title>
          <source>JAMA</source>
          <year>2003</year>
          <volume>289</volume>
          <fpage>1537</fpage>
          <lpage>1545</lpage>
          <pub-id pub-id-type="pmid">12672771</pub-id>
        </element-citation>
      </ref>
      <ref id="B7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krome</surname>
              <given-names>CN</given-names>
            </name>
            <name>
              <surname>Tucker</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Cardiac arrhythmia in a professional football player: Was ephedrine to blame?</article-title>
          <source>Phys Sportsmed</source>
          <year>2003</year>
          <volume>31</volume>
          <fpage>21</fpage>
          <lpage>25</lpage>
          <fpage>29</fpage>
          <pub-id pub-id-type="pmid">20086449</pub-id>
        </element-citation>
      </ref>
      <ref id="B8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rezkalla</surname>
              <given-names>SH</given-names>
            </name>
            <name>
              <surname>Mesa</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Sharma</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kloner</surname>
              <given-names>RA</given-names>
            </name>
          </person-group>
          <article-title>Myocardial infarction temporally related to ephedra-a possible role for the coronary microcirculation</article-title>
          <source>WMJ</source>
          <year>2002</year>
          <volume>101</volume>
          <fpage>64</fpage>
          <lpage>66</lpage>
          <pub-id pub-id-type="pmid">12426924</pub-id>
        </element-citation>
      </ref>
      <ref id="B9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Naik</surname>
              <given-names>SD</given-names>
            </name>
            <name>
              <surname>Freudenberger</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Ephedra-associated cardiomyopathy</article-title>
          <source>Ann Pharmacother</source>
          <year>2004</year>
          <volume>38</volume>
          <fpage>400</fpage>
          <lpage>403</lpage>
          <pub-id pub-id-type="pmid">14742827</pub-id>
        </element-citation>
      </ref>
      <ref id="B10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Biller</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Willing</surname>
              <given-names>SJ</given-names>
            </name>
            <name>
              <surname>Lopez</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Ischemic stroke after using over the counter products containing ephedra</article-title>
          <source>J Neurol Sci</source>
          <year>2004</year>
          <volume>217</volume>
          <fpage>55</fpage>
          <lpage>60</lpage>
          <pub-id pub-id-type="pmid">14675610</pub-id>
        </element-citation>
      </ref>
      <ref id="B11">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charatan</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Ephedra supplement may have contributed to sportsman's death</article-title>
          <source>BMJ</source>
          <year>2003</year>
          <volume>326</volume>
          <fpage>464</fpage>
          <pub-id pub-id-type="pmid">12609922</pub-id>
        </element-citation>
      </ref>
      <ref id="B12">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalman</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Incledon</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Gaunaurd</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Krieger</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>An acute clinical trial evaluating the cardiovascular effects of an herbal ephedra-caffeine weight loss product in healthy overweight adults</article-title>
          <source>Int J Obes Relat Metab Disord</source>
          <year>2002</year>
          <volume>26</volume>
          <fpage>1363</fpage>
          <lpage>1366</lpage>
          <pub-id pub-id-type="pmid">12355332</pub-id>
        </element-citation>
      </ref>
      <ref id="B13">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Haller</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Jacob</surname>
              <given-names>P</given-names>
              <suffix>3rd</suffix>
            </name>
            <name>
              <surname>Benowitz</surname>
              <given-names>NL</given-names>
            </name>
          </person-group>
          <article-title>Pharmacology of ephedra alkaloids and caffeine after single-dose dietary supplement use</article-title>
          <source>Clin Pharmacol Ther</source>
          <year>2002</year>
          <volume>71</volume>
          <fpage>421</fpage>
          <lpage>432</lpage>
          <pub-id pub-id-type="pmid">12087345</pub-id>
        </element-citation>
      </ref>
      <ref id="B14">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McBride</surname>
              <given-names>BF</given-names>
            </name>
            <name>
              <surname>Karapanos</surname>
              <given-names>AK</given-names>
            </name>
            <name>
              <surname>Krudysz</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Kluger</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Coleman</surname>
              <given-names>CI</given-names>
            </name>
            <name>
              <surname>White</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial</article-title>
          <source>JAMA</source>
          <year>2004</year>
          <volume>291</volume>
          <fpage>216</fpage>
          <lpage>221</lpage>
          <pub-id pub-id-type="pmid">14722148</pub-id>
        </element-citation>
      </ref>
      <ref id="B15">
        <label>15</label>
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Jellin</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Gregory</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Batz</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Hitchens</surname>
              <given-names>K</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Ephedra</article-title>
          <source>Natural medicines comprehensive database</source>
          <year>2000</year>
          <edition>3rd ed</edition>
          <publisher-loc>Stockton, CA</publisher-loc>
          <publisher-name>Therapeutic Research Faculty</publisher-name>
          <fpage>400</fpage>
          <lpage>403</lpage>
        </element-citation>
      </ref>
      <ref id="B16">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lichtenstein</surname>
              <given-names>GR</given-names>
            </name>
            <name>
              <surname>Yee</surname>
              <given-names>NS</given-names>
            </name>
          </person-group>
          <article-title>Ischemic colitis associated with decongestant use</article-title>
          <source>Ann Intern Med</source>
          <year>2000</year>
          <volume>132</volume>
          <fpage>682</fpage>
          <pub-id pub-id-type="pmid">10766702</pub-id>
        </element-citation>
      </ref>
      <ref id="B17">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dowd</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Bailey</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Moussa</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Nair</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Doyle</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Culpepper-Morgan</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Ischemic colitis associated with pseudoephedrine: four cases</article-title>
          <source>Am J Gastroenterol</source>
          <year>1999</year>
          <volume>94</volume>
          <fpage>2430</fpage>
          <lpage>2434</lpage>
          <pub-id pub-id-type="pmid">10484004</pub-id>
        </element-citation>
      </ref>
      <ref id="B18">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Comay</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ramsay</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Irvine</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Ischemic colitis after weight-loss medication</article-title>
          <source>Can J Gastroenterol</source>
          <year>2003</year>
          <volume>17</volume>
          <fpage>719</fpage>
          <lpage>721</lpage>
          <pub-id pub-id-type="pmid">14679420</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="F1" position="float">
      <label>Fig. 1</label>
      <caption>
        <p>Abdominal and pelvic CT scans show a patent superior mesenteric artery (A) and edematous circumferential wall thickening of the ascending, transverse, and descending colon (B).</p>
      </caption>
      <graphic xlink:href="ymj-49-496-g001"/>
    </fig>
    <fig id="F2" position="float">
      <label>Fig. 2</label>
      <caption>
        <p>(A) Colonoscopy on admission show hemorrhagic friable mucosal patches with mucosal edema from the ascending to the descending colon. (B) Colonoscopy at an 8-day follow-up show marked mucosal improvement.</p>
      </caption>
      <graphic xlink:href="ymj-49-496-g002"/>
    </fig>
    <fig id="F3" position="float">
      <label>Fig. 3</label>
      <caption>
        <p>Colonoscopic biopsy specimen from the transverse colon show focal mucosal erosion and chronic inflammatory cell infiltration (H&amp;E stain, &#xD7; 200).</p>
      </caption>
      <graphic xlink:href="ymj-49-496-g003"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
